Board Certified Ambulatory Care Pharmacist (BCACP) Exam — Questions and Answers

Question 1: A pharmacist applying for the BCACP exam for the first time must meet which minimum practice eligibility requirement?

Board certification in pharmacotherapy (BCPS) is required first
Active licensure plus at least 50% of practice time in ambulatory care for the past 3 years or an APhA fellowship (Correct answer)
5 years of any clinical pharmacy experience
Completion of a PGY-1 residency only

Correct answer: Active licensure plus at least 50% of practice time in ambulatory care for the past 3 years or an APhA fellowship

BPS requires current licensure and at least 50% of practice time in ambulatory care over the 3 years prior to application.

Question 2: A patient with T2DM and an eGFR of 38 mL/min/1.73m² is currently on metformin 1000 mg twice daily. What is the most appropriate action?

Discontinue metformin (Correct answer)
Reduce metformin dose to 500 mg twice daily
Continue metformin at current dose
Switch to metformin XR 2000 mg daily

Correct answer: Discontinue metformin

Metformin is contraindicated when eGFR falls below 30 and should be discontinued at eGFR <30; at eGFR 30-45 it should be used with caution at reduced doses, but eGFR 38 warrants discontinuation per many guidelines.

Question 3: A pharmacist is recognized for developing a clinical service that improves diabetes management in an underserved community. What type of professional recognition is MOST appropriate for this achievement?

Becoming a preceptor for a pharmacy school
Obtaining a Medication Therapy Management (MTM) certification
Credentialing as BCACP
Receiving a local or national pharmacy award (Correct answer)

Correct answer: Receiving a local or national pharmacy award

Developing a successful clinical service that significantly improves patient outcomes, especially in an underserved community, is a substantial achievement that warrants public recognition. Receiving a local or national pharmacy award specifically acknowledges such innovative contributions and leadership in advancing pharmacy practice. These awards highlight excellence and impact, distinguishing significant professional achievements beyond standard certifications or roles.

Question 4: When using the HAS-BLED score in a patient with atrial fibrillation, what does a score of ≥3 indicate?

High risk of bleeding, warrants caution and closer monitoring (Correct answer)
DOAC is preferred over warfarin
Anticoagulation is absolutely contraindicated
High risk of stroke without anticoagulation

Correct answer: High risk of bleeding, warrants caution and closer monitoring

HAS-BLED ≥3 indicates high bleeding risk, prompting caution and more frequent monitoring, but is not a contraindication to anticoagulation.

Question 5: Which beta-blocker has the strongest evidence for mortality reduction in patients with HFrEF and should be used preferentially?

Labetalol
Atenolol
Propranolol
Carvedilol, metoprolol succinate, or bisoprolol (Correct answer)

Correct answer: Carvedilol, metoprolol succinate, or bisoprolol

Only carvedilol, metoprolol succinate (extended-release), and bisoprolol have demonstrated mortality benefit in large HFrEF trials and are guideline-recommended.

Question 6: A pharmacist identifies a low-income patient who cannot afford their prescribed antihypertensive. The MOST appropriate next step is:

Assess eligibility for patient assistance programs or lower-cost therapeutic alternatives (Correct answer)
Recommend the patient purchase only half the prescribed quantity
Document the issue and defer to the physician
Advise the patient to skip doses to extend the supply

Correct answer: Assess eligibility for patient assistance programs or lower-cost therapeutic alternatives

Identifying cost assistance programs or therapeutically equivalent lower-cost alternatives directly addresses a modifiable adherence barrier.

Question 7: A clinical trial evaluates a new medication for stroke prevention in patients with atrial fibrillation. The results for the primary outcome of ischemic stroke are reported as a Hazard Ratio (HR) of 0.80 with a 95% Confidence Interval (CI) of 0.65 to 1.05. Which of the following is the most accurate interpretation of this finding?

The new medication is inferior to the comparator for stroke prevention.
The result is not statistically significant. (Correct answer)
The p-value must be less than 0.05.
The new medication is superior to the comparator for stroke prevention.

Correct answer: The result is not statistically significant.

For a ratio metric like a Hazard Ratio (HR), Relative Risk (RR), or Odds Ratio (OR), the null value (representing no difference between groups) is 1.0. A 95% Confidence Interval indicates a range where the true effect is likely to lie. Because this 95% CI (0.65 to 1.05) crosses 1.0, we cannot exclude the possibility of no difference. Therefore, the result is not statistically significant at the p<0.05 level.

Question 8: A patient on warfarin has a new prescription for fluconazole for a vaginal infection. What is the expected interaction?

Fluconazole decreases warfarin effect by inducing CYP2C9
Fluconazole decreases warfarin absorption
No clinically significant interaction exists
Fluconazole increases warfarin effect by inhibiting CYP2C9 (Correct answer)

Correct answer: Fluconazole increases warfarin effect by inhibiting CYP2C9

Fluconazole is a potent CYP2C9 inhibitor, reducing warfarin metabolism and significantly increasing INR.

Question 9: A pharmacist reviews a prescription for clopidogrel in a patient on omeprazole. What is the clinical significance of this interaction?

Omeprazole induces CYP2C19, increasing clopidogrel's active metabolite
Omeprazole inhibits CYP2C19, reducing conversion of clopidogrel to its active metabolite (Correct answer)
The interaction only applies to IV omeprazole formulations
Omeprazole reduces clopidogrel absorption by raising gastric pH

Correct answer: Omeprazole inhibits CYP2C19, reducing conversion of clopidogrel to its active metabolite

Omeprazole inhibits CYP2C19, the enzyme responsible for converting clopidogrel to its active thiol metabolite, potentially reducing antiplatelet efficacy.

Question 10: A 55-year-old female with a history of a myocardial infarction 2 years ago is on atorvastatin 80 mg daily. Her recent LDL-C is 85 mg/dL. Her other medications are maximized and she is adherent. According to the 2026 ACC/AHA Dyslipidemia Guideline, what is the most appropriate recommendation to further reduce her ASCVD risk?

Continue current therapy as LDL-C goal is met.
Switch atorvastatin to rosuvastatin 40 mg daily.
Add ezetimibe 10 mg daily. (Correct answer)
Add fenofibrate to her current regimen.

Correct answer: Add ezetimibe 10 mg daily.

For patients with clinical ASCVD at very high risk, the 2026 ACC/AHA guideline recommends an LDL-C goal of <55 mg/dL. Since the patient is on a maximally tolerated high-intensity statin and her LDL-C is above this goal, adding a non-statin agent like ezetimibe is the most appropriate next step to further lower LDL-C. Fenofibrate is not indicated for LDL lowering in this context. Switching to another high-intensity statin may provide a small additional reduction, but adding ezetimibe is a more effective and guideline-supported strategy.

Question 11: Which GLP-1 receptor agonist is FDA-approved for once-weekly subcutaneous injection and has demonstrated cardiovascular outcome benefits in the LEADER trial?

Liraglutide (Correct answer)
Dulaglutide
Semaglutide
Exenatide extended-release

Correct answer: Liraglutide

Liraglutide (Victoza) was studied in the LEADER trial, demonstrating significant reduction in major adverse cardiovascular events in high-risk T2DM patients.

Question 12: A patient with schizophrenia is inconsistently adherent to their antipsychotic medication. The MOST patient-centered intervention would be to:

Provide written reminders and discharge the patient from care
Switch to a longer-acting injectable formulation without discussion
Notify the prescriber to add a second antipsychotic
Explore the patient's barriers to adherence and collaboratively develop solutions (Correct answer)

Correct answer: Explore the patient's barriers to adherence and collaboratively develop solutions

Collaboratively identifying adherence barriers respects the patient's perspective and increases the likelihood of finding a sustainable solution.

Question 13: A pharmacist is considering whether to pursue BCACP or BCPS certification. The pharmacist practices exclusively in a primary care clinic managing chronic diseases. Which certification is most appropriate?

Neither; the pharmacist should pursue a fellowship instead
BCACP, because it specifically validates competency in ambulatory care practice (Correct answer)
BCPS, because it covers a broader scope of pharmacotherapy
Either credential is equivalent for ambulatory care positions

Correct answer: BCACP, because it specifically validates competency in ambulatory care practice

BCACP is specifically designed to validate competence in ambulatory care pharmacy, making it the most relevant credential for this practice setting.

Question 14: A patient on apixaban 5 mg twice daily for atrial fibrillation develops end-stage renal disease requiring hemodialysis. What is the most appropriate action?

Discontinue all anticoagulation
Switch to warfarin with target INR 2.0–3.0
Continue apixaban 5 mg twice daily (Correct answer)
Reduce apixaban to 2.5 mg twice daily

Correct answer: Continue apixaban 5 mg twice daily

Apixaban is now FDA-approved for use in ESKD patients on dialysis at the standard 5 mg twice daily dose based on pharmacokinetic data and clinical studies.

Question 15: Which of the following is a contraindication to initiating ACE inhibitor therapy?

Heart failure with reduced EF
Bilateral renal artery stenosis (Correct answer)
Proteinuric CKD
Microalbuminuria in type 1 diabetes

Correct answer: Bilateral renal artery stenosis

Bilateral renal artery stenosis is a contraindication to ACE inhibitors because they can precipitate acute renal failure in this setting.

Question 16: A patient with peripheral artery disease (ABI = 0.75) and hypertension needs antihypertensive therapy. Which drug class is NOT contraindicated in PAD and can be used safely?

ACE inhibitors
Beta-blockers
All of the above (Correct answer)
Calcium channel blockers

Correct answer: All of the above

All major antihypertensive classes including ACE inhibitors, CCBs, and beta-blockers can be used in PAD; the priority is achieving BP control.

Question 17: A patient with ulcerative colitis limited to the rectum (proctitis) presents with mild-to-moderate active disease. Which formulation of mesalamine is MOST appropriate as first-line therapy for this presentation?

Combination of oral and rectal mesalamine
Oral mesalamine (delayed-release tablet) alone
Mesalamine rectal suppository alone (Correct answer)
Systemic corticosteroids (prednisone) as initial therapy

Correct answer: Mesalamine rectal suppository alone

For mild-to-moderate ulcerative proctitis, topical (rectal) mesalamine formulations (suppositories or enemas) are the preferred first-line therapy. Suppositories deliver drug directly to the affected mucosa in proctitis. ACG guidelines indicate topical 5-ASA is superior to oral 5-ASA for proctitis and is more effective than topical corticosteroids. Systemic corticosteroids are reserved for more severe or refractory disease. Combination therapy (oral + rectal) is an option for more extensive disease or if topical alone is insufficient.

Question 18: A study has a wide 95% confidence interval crossing 1.0 for an odds ratio. What does this indicate?

The intervention is harmful
The result is clinically insignificant
There is high precision in the estimate
The result is not statistically significant (Correct answer)

Correct answer: The result is not statistically significant

A 95% CI for an odds ratio that includes 1.0 indicates no statistically significant difference between groups.

Question 19: A pharmacy manager wants to demonstrate the impact of a clinical pharmacy program using a 'return on investment' (ROI) framework. Which data would be MOST relevant?

Number of pharmacist interventions documented per month
Formulary compliance rates for tier-1 medications
Cost savings from avoided hospitalizations versus program operating costs (Correct answer)
Patient satisfaction scores and wait times

Correct answer: Cost savings from avoided hospitalizations versus program operating costs

ROI requires comparing the financial value of outcomes achieved (e.g., avoided hospitalizations) to the cost of delivering the program.

Question 20: An ambulatory care pharmacist is educating a patient on proper home blood pressure monitoring technique. Which of the following instructions is INACCURATE and could lead to a falsely elevated reading?

"Place the cuff over a long-sleeved shirt to ensure it is snug." (Correct answer)
"Sit with your back supported and your feet flat on the floor."
"Support your arm on a table so the cuff is at the level of your heart."
"Rest quietly in a chair for at least 5 minutes before taking a measurement."

Correct answer: "Place the cuff over a long-sleeved shirt to ensure it is snug."

Blood pressure cuffs should always be placed on a bare arm, not over clothing. Placing the cuff over a sleeve can interfere with the artery compression and lead to a falsely elevated blood pressure reading. The other options represent correct procedures for accurate measurement according to AHA/ACC guidelines.

Question 21: A patient with chronic low back pain and depression is seeking pharmacological treatment that may address both conditions. Which non-opioid analgesic class has dual evidence for both chronic musculoskeletal pain and depression?

Topical diclofenac
COX-2 inhibitors (e.g., celecoxib)
SNRIs (e.g., duloxetine) (Correct answer)
Gabapentin

Correct answer: SNRIs (e.g., duloxetine)

SNRIs such as duloxetine (Cymbalta) are FDA-approved for both major depressive disorder and chronic musculoskeletal pain conditions including chronic low back pain, diabetic peripheral neuropathy, and fibromyalgia. This dual mechanism (norepinephrine and serotonin reuptake inhibition) provides analgesic and antidepressant effects. COX-2 inhibitors and topical diclofenac have analgesic but no antidepressant properties. Gabapentin treats neuropathic pain but is not approved for depression.

Question 22: What does the number needed to harm (NNH) represent?

The relative increase in adverse events compared to placebo
The probability of a patient experiencing harm
The number of patients who must receive a treatment for one additional patient to experience harm (Correct answer)
The number of harmful events prevented per 100 patients

Correct answer: The number of patients who must receive a treatment for one additional patient to experience harm

NNH = 1/absolute risk increase, representing how many patients need treatment before one additional adverse outcome occurs.

Question 23: A patient prescribed clozapine develops an absolute neutrophil count (ANC) of 450 cells/µL. What is the most appropriate action?

Add G-CSF and continue clozapine at current dose
Continue clozapine and recheck ANC in 1 week
Immediately discontinue clozapine and monitor ANC daily (Correct answer)
Reduce clozapine dose by 50%

Correct answer: Immediately discontinue clozapine and monitor ANC daily

An ANC below 500 cells/µL indicates severe neutropenia requiring immediate clozapine discontinuation per the Clozapine REMS program requirements.

Question 24: Which fibrate carries the lowest risk of myopathy when used in combination with a statin?

Gemfibrozil
Clofibrate
Fenofibrate (Correct answer)
All fibrates carry equal risk

Correct answer: Fenofibrate

Fenofibrate does not inhibit glucuronidation of statins (unlike gemfibrozil) and therefore carries a significantly lower risk of statin-associated myopathy.

Question 25: A patient with CKD stage 3b (eGFR 38 mL/min/1.73m²) is prescribed metformin. What is the most appropriate action?

Switch to insulin only
Discontinue metformin immediately
Reduce metformin dose and monitor renal function every 3 months (Correct answer)
Continue metformin at full dose

Correct answer: Reduce metformin dose and monitor renal function every 3 months

Metformin can be continued with dose reduction at eGFR 30-45 mL/min/1.73m² with close monitoring, but should be discontinued if eGFR falls below 30.

Question 26: A pharmacist is counseling a patient starting isotretinoin. Which program must the patient be enrolled in before dispensing?

REMS with ETASU
Clozapine REMS
TIRF REMS Access program
iPLEDGE program (Correct answer)

Correct answer: iPLEDGE program

iPLEDGE is the mandatory REMS program for isotretinoin due to its severe teratogenic potential, requiring monthly pregnancy testing for females of reproductive potential.

Question 27: Which reimbursement mechanism most directly supports pharmacist-provided Medication Therapy Management (MTM) services under Medicare?

Medicare Part D standalone MTM program funding (Correct answer)
Medicare Advantage supplemental benefit payments
Medicare Part A inpatient DRG payments
Medicare Part B incident-to billing

Correct answer: Medicare Part D standalone MTM program funding

Medicare Part D requires Prescription Drug Plans to provide MTM programs for targeted beneficiaries, funding pharmacist-delivered services.

Question 28: A 68-year-old African American male presents for a follow-up visit for his hypertension. His current blood pressure is 148/92 mmHg. His current medications include lisinopril 40 mg daily. He has no other compelling indications. According to the JNC 8 guidelines, which of the following is the most appropriate next step in managing his hypertension?

Add metoprolol succinate 50 mg daily.
Add losartan 50 mg daily.
Increase lisinopril to 80 mg daily.
Add amlodipine 5 mg daily. (Correct answer)

Correct answer: Add amlodipine 5 mg daily.

JNC 8 guidelines recommend initial or add-on antihypertensive treatment with a thiazide diuretic or a calcium channel blocker (CCB) for black patients. Since the patient is already on an ACE inhibitor without adequate control, adding a CCB like amlodipine is a recommended next step. Increasing the ACE inhibitor or adding an ARB would be less effective in this patient population, and a beta-blocker is not a first-line agent unless there is a specific indication like post-MI or heart failure.

Question 29: A pharmacist notices that a patient's prescription for an antidepressant was filled only once and not refilled after 30 days. What is the MOST appropriate action?

Send a refill reminder and document the gap without follow-up
Proactively contact the patient to assess barriers, address concerns about the medication, and reinforce the importance of consistent use (Correct answer)
Notify the prescriber to switch to a different antidepressant
Assume the patient is now in remission and no action is needed

Correct answer: Proactively contact the patient to assess barriers, address concerns about the medication, and reinforce the importance of consistent use

Early antidepressant discontinuation is common due to side effects or perceived lack of efficacy; proactive outreach addresses barriers and educates patients that therapeutic benefits often take weeks to appear.

Question 30: Which validated tool is MOST commonly used in ambulatory care to assess a patient's risk for opioid misuse or aberrant drug-related behaviors BEFORE initiating long-term opioid therapy?

AUDIT-C (Alcohol Use Disorders Identification Test)
CAGE questionnaire
PHQ-9 (Patient Health Questionnaire-9)
ORT (Opioid Risk Tool) (Correct answer)

Correct answer: ORT (Opioid Risk Tool)

The Opioid Risk Tool (ORT) is a brief, validated 5-item screening tool specifically designed to predict aberrant drug-related behaviors in patients prescribed opioids for chronic pain. It stratifies patients as low, moderate, or high risk. PHQ-9 screens for depression. AUDIT-C and CAGE screen for alcohol use disorder. While all may provide useful clinical context, the ORT is the tool designed specifically for pre-opioid prescribing risk assessment.

Question 31: A patient with type 2 diabetes has an A1C of 9.2% and states he does not want insulin. The BCACP pharmacist should:

Accept the A1C as the patient's preferred level
Explore the patient's concerns about insulin and discuss non-insulin intensification options (Correct answer)
Refer the patient back to the physician without further discussion
Initiate insulin anyway to meet the guideline target

Correct answer: Explore the patient's concerns about insulin and discuss non-insulin intensification options

Exploring insulin concerns and presenting alternatives honors patient autonomy while working toward glycemic targets within the shared decision-making framework.

Question 32: Which of the following clotting factors is NOT inhibited by warfarin?

Factor X
Factor VIII (Correct answer)
Factor II (Thrombin)
Factor VII

Correct answer: Factor VIII

Warfarin inhibits only vitamin K-dependent clotting factors (II, VII, IX, X); Factor VIII is not vitamin K-dependent and is therefore unaffected.

Question 33: A funnel plot in a meta-analysis is asymmetrical. This finding most likely indicates:

The pooled effect is not statistically significant
Publication bias may be present (Correct answer)
High heterogeneity among included studies
The meta-analysis included too few studies

Correct answer: Publication bias may be present

Asymmetry in a funnel plot suggests smaller studies with negative results may not have been published, indicating publication bias.

Question 34: A 62-year-old male patient with a recent STEMI is discharged on dual antiplatelet therapy (aspirin + ticagrelor). When should aspirin be taken relative to ticagrelor to avoid reduced efficacy?

Aspirin doses should be limited to ≤100 mg/day; high-dose aspirin blunts ticagrelor's antiplatelet effect (Correct answer)
Aspirin and ticagrelor timing has no effect on efficacy
Aspirin should be taken at least 4 hours before ticagrelor
Aspirin should be taken at night while ticagrelor is taken in the morning

Correct answer: Aspirin doses should be limited to ≤100 mg/day; high-dose aspirin blunts ticagrelor's antiplatelet effect

High-dose aspirin (>100 mg/day) paradoxically attenuates ticagrelor's antiplatelet effect by blocking prostacyclin synthesis; aspirin should be maintained at ≤100 mg/day.

Question 35: A pharmacist reviews a trial where the primary endpoint was changed after enrollment began but before unblinding. This is an example of:

Outcome reporting bias (Correct answer)
Detection bias
Attrition bias
Allocation concealment failure

Correct answer: Outcome reporting bias

Changing the primary endpoint after trial initiation but before unblinding introduces outcome reporting bias.

Question 36: A 70-year-old female with type 2 diabetes and recently diagnosed heart failure with preserved ejection fraction (HFpEF) has an A1c of 7.9%. Her current regimen includes metformin and sitagliptin. Which of the following medications should be added to provide both glycemic improvement and a reduction in heart failure hospitalizations?

Dapagliflozin (Correct answer)
Glimepiride
Liraglutide
Pioglitazone

Correct answer: Dapagliflozin

SGLT2 inhibitors, such as dapagliflozin and empagliflozin, are recommended in the 2022 AHA/ACC/HFSA heart failure guidelines for patients with HFpEF (Class 2a recommendation) to reduce the risk of heart failure hospitalizations and improve symptoms, regardless of diabetes status. They also provide glycemic control. Pioglitazone can cause fluid retention and should be avoided in heart failure. While liraglutide offers ASCVD benefits, its primary benefit is not in reducing HF hospitalizations in HFpEF. Glimepiride offers no cardiovascular or heart failure benefits.

Question 37: Which bisphosphonate formulation requires the patient to remain upright for 30 minutes after administration?

Ibandronate IV injection
Zoledronic acid IV infusion
Alendronate oral tablet (Correct answer)
Pamidronate IV infusion

Correct answer: Alendronate oral tablet

Oral alendronate must be taken with a full glass of water on an empty stomach, and the patient must remain upright for at least 30 minutes to prevent esophageal irritation.

Question 38: A pharmacist working in a Federally Qualified Health Center (FQHC) can bill for clinical services using which designation that allows direct reimbursement?

Dispenser of Record
Eligible Professional under FQHC cost-based reimbursement (Correct answer)
Pharmacist Provider Status under all state Medicaid programs
Incident-to billing only

Correct answer: Eligible Professional under FQHC cost-based reimbursement

FQHCs use a cost-based prospective payment system that can include pharmacist services as covered encounters when approved under the clinic's approved scope of services.

Question 39: Which of the following vaccinations is recommended by the CDC for all unvaccinated adults aged 19-59 with diabetes mellitus, to be administered as soon as feasible after diagnosis?

A. Zoster vaccine (RZV)
D. Hepatitis B virus (HBV) vaccine (Correct answer)
C. Measles, mumps, and rubella (MMR) vaccine
B. Human papillomavirus (HPV) vaccine

Correct answer: D. Hepatitis B virus (HBV) vaccine

The CDC specifically recommends the Hepatitis B vaccine for all unvaccinated adults aged 19 through 59 years with diabetes. This recommendation is due to the increased risk of Hepatitis B transmission through shared blood glucose monitoring equipment. For adults 60 years or older with diabetes who have not previously received the vaccine, it may be administered at the discretion of the healthcare provider. While other vaccines like Zoster, HPV, and MMR are important, the HBV vaccine has a specific recommendation for this age group of adults with diabetes.

Question 40: A patient is prescribed trimethoprim-sulfamethoxazole for a urinary tract infection. Which monitoring parameter is most important in a patient with chronic kidney disease?

Liver function tests
CBC only
Blood glucose
Serum creatinine and potassium (Correct answer)

Correct answer: Serum creatinine and potassium

TMP-SMX can increase serum creatinine (by blocking tubular secretion) and potassium, requiring close monitoring in CKD patients.

Question 41: What is the recommended post-exposure prophylaxis (PEP) window for HIV initiation after a high-risk exposure?

Within 2 weeks
Within 72 hours (Correct answer)
Within 1 week
Within 24 hours only

Correct answer: Within 72 hours

HIV PEP must be initiated within 72 hours of exposure and continued for 28 days to be effective.

Question 42: Which measure is an example of a process measure in ambulatory pharmacy quality reporting?

All-cause hospitalization rate
Percentage of diabetic patients with HbA1c tested annually (Correct answer)
30-day readmission rate
Mortality rate from cardiovascular events

Correct answer: Percentage of diabetic patients with HbA1c tested annually

Process measures assess whether recommended care steps are performed, such as annual HbA1c testing for diabetic patients, rather than the final health outcome.

Question 43: The Pharmacy Quality Alliance (PQA) measure 'Medication Adherence for Diabetes Medications' uses which metric to assess adherence?

Medication Possession Ratio (MPR) >0.70
Proportion of Days Covered (PDC) ≥0.80 (Correct answer)
Patient-reported adherence score ≥85%
Number of refills dispensed per year ≥10

Correct answer: Proportion of Days Covered (PDC) ≥0.80

PQA adherence measures use PDC ≥0.80 (80%) as the threshold for 'adherent,' as PDC is considered more rigorous than MPR.

Question 44: A 52-year-old female is diagnosed with Stage 1 hypertension with a blood pressure reading of 136/88 mmHg. She has no other medical conditions. Her calculated 10-year PREVENT-ASCVD risk score is 4%. Based on the 2025 ACC/AHA hypertension guideline, what is the MOST appropriate initial recommendation?

Recommend lifestyle modifications and re-evaluate in 1 month.
Initiate amlodipine 5 mg daily.
Recommend lifestyle modifications, including dietary changes and physical activity, and re-evaluate in 3-6 months. (Correct answer)
Initiate hydrochlorothiazide 12.5 mg daily.

Correct answer: Recommend lifestyle modifications, including dietary changes and physical activity, and re-evaluate in 3-6 months.

The 2025 ACC/AHA hypertension guideline recommends initiating antihypertensive medication for Stage 1 hypertension if the patient has clinical ASCVD or a 10-year PREVENT risk of ≥7.5%. For patients with Stage 1 hypertension and a lower risk (<7.5%), a 3- to 6-month trial of lifestyle modification is recommended before initiating pharmacotherapy.

Question 45: A patient with heart failure with reduced ejection fraction (HFrEF) asks about dietary modifications. What is the recommended daily sodium limit?

Less than 2,000–3,000 mg/day (Correct answer)
Less than 1,000 mg/day
Less than 4,000 mg/day
Less than 1,500 mg/day

Correct answer: Less than 2,000–3,000 mg/day

ACC/AHA guidelines recommend limiting sodium to less than 2,000–3,000 mg/day in HFrEF patients to reduce fluid retention and hospitalizations.

Question 46: For a patient with a first UNPROVOKED proximal DVT at low-to-moderate bleeding risk, what does current ACCP/ASH guidance recommend regarding anticoagulation duration?

Extended (indefinite) anticoagulation with periodic reassessment of bleeding risk (Correct answer)
12 months, then stop anticoagulation
6 months, then reassess annually with possible discontinuation
3 months, then stop anticoagulation

Correct answer: Extended (indefinite) anticoagulation with periodic reassessment of bleeding risk

Guidelines recommend extended (indefinite) anticoagulation for a first unprovoked DVT at low-to-moderate bleeding risk due to the high recurrence rate (~30% at 5 years) without ongoing therapy.

Question 47: A patient with heart failure with reduced ejection fraction (HFrEF) and CKD stage 3b (eGFR 32 mL/min) is started on sacubitril/valsartan. Which monitoring parameter is most critical in the first month?

Complete blood count
Serum potassium and creatinine (Correct answer)
Thyroid-stimulating hormone
Liver function tests

Correct answer: Serum potassium and creatinine

Sacubitril/valsartan can cause hyperkalemia and worsen renal function, especially in patients with pre-existing CKD, requiring close monitoring of potassium and creatinine.

Question 48: Andexanet alfa (Andexxa) is FDA-approved for reversal of which anticoagulants in life-threatening bleeding?

Warfarin and fondaparinux
Unfractionated heparin and enoxaparin
Rivaroxaban and apixaban (Correct answer)
Dabigatran and argatroban

Correct answer: Rivaroxaban and apixaban

Andexanet alfa is a modified recombinant Factor Xa decoy protein approved for reversing rivaroxaban and apixaban (both Factor Xa inhibitors) in life-threatening bleeding.

Question 49: A patient with a mechanical mitral valve requires anticoagulation. Which regimen is most appropriate?

Warfarin with a target INR of 2.5–3.5 (Correct answer)
Dabigatran 150 mg twice daily
Warfarin with a target INR of 2.0–3.0
Apixaban 5 mg twice daily

Correct answer: Warfarin with a target INR of 2.5–3.5

Mechanical mitral valves require warfarin with a higher INR target of 2.5–3.5; DOACs are contraindicated for mechanical valves.

Question 50: Which medication used in T2DM requires monitoring of liver function tests due to risk of hepatotoxicity and fluid retention?

Pioglitazone (Correct answer)
Sitagliptin
Canagliflozin
Metformin

Correct answer: Pioglitazone

Thiazolidinediones like pioglitazone can cause fluid retention and weight gain; while hepatotoxicity was a major concern with troglitazone (withdrawn), LFT monitoring and awareness of edema risk remain relevant.

Question 51: Which type of study is most susceptible to recall bias?

Randomized controlled trial
Crossover trial
Case-control study (Correct answer)
Prospective cohort study

Correct answer: Case-control study

Case-control studies rely on participants recalling past exposures, making them vulnerable to recall bias.

Question 52: Which anticoagulant regimen is now preferred over LMWH for cancer-associated thrombosis in patients without high gastrointestinal or genitourinary bleeding risk?

Apixaban or rivaroxaban (direct oral anticoagulants) (Correct answer)
Aspirin 81 mg plus clopidogrel 75 mg
Fondaparinux subcutaneous injection
Warfarin with target INR 2.0–3.0

Correct answer: Apixaban or rivaroxaban (direct oral anticoagulants)

Updated ISTH and ASCO guidelines recommend DOACs (apixaban or rivaroxaban) over LMWH as preferred therapy for cancer-associated thrombosis in appropriate patients.

Question 53: A patient is newly prescribed digoxin for rate control in atrial fibrillation with HFrEF. Which serum digoxin level range is associated with optimal outcomes in HFrEF patients?

2.0–3.0 ng/mL
Any level below 2.0 ng/mL is acceptable
1.0–2.0 ng/mL
0.5–0.9 ng/mL (Correct answer)

Correct answer: 0.5–0.9 ng/mL

Post-hoc analyses of the DIG trial showed that digoxin levels of 0.5–0.9 ng/mL are associated with reduced hospitalizations and mortality in HFrEF, while higher levels increase mortality risk.

Question 54: Which patient characteristic is MOST strongly associated with poor medication adherence in chronic disease management?

Being over age 65
Taking medications for less than 3 months
Asymptomatic disease combined with complex medication regimens (Correct answer)
Having insurance coverage

Correct answer: Asymptomatic disease combined with complex medication regimens

Asymptomatic diseases remove the reinforcement of symptom relief, and complex regimens increase the burden of adherence, combining to create significant non-adherence risk.

Question 55: Which pharmacoeconomic analysis determines the cost per quality-adjusted life year (QALY) gained?

Cost-minimization analysis
Cost-utility analysis (Correct answer)
Cost-benefit analysis
Cost-effectiveness analysis

Correct answer: Cost-utility analysis

Cost-utility analysis incorporates patient preferences using QALYs to compare interventions.

Question 56: Which statistical test is most appropriate for comparing means across three or more independent groups in a clinical trial?

Chi-square test
Paired t-test
One-way ANOVA (Correct answer)
Pearson correlation

Correct answer: One-way ANOVA

One-way ANOVA compares means among three or more independent groups simultaneously.

Question 57: A patient asks about receiving the COVID-19 vaccine during a routine ambulatory visit. Which statement accurately reflects current vaccination guidance?

COVID-19 vaccines require a 4-week interval before any other vaccine
Updated COVID-19 vaccines can be co-administered with other vaccines at the same visit (Correct answer)
Only individuals over 65 need the COVID-19 vaccine
COVID-19 vaccines should not be co-administered with other vaccines

Correct answer: Updated COVID-19 vaccines can be co-administered with other vaccines at the same visit

CDC guidance states that COVID-19 vaccines may be co-administered with other vaccines without waiting periods.

Question 58: When evaluating a population-based intervention, a 'balancing measure' is used to:

Assess patient satisfaction with the intervention
Detect unintended negative consequences of the intervention (Correct answer)
Confirm that the primary outcome improved
Compare costs before and after implementation

Correct answer: Detect unintended negative consequences of the intervention

Balancing measures monitor for unintended harms or trade-offs caused by an improvement effort, ensuring the intervention doesn't cause problems elsewhere.

Question 59: Which of the following best defines 'health equity' in the context of population-based pharmacy practice?

Ensuring every patient receives the same number of pharmacy visits
Achieving the highest level of health for all people by addressing systemic barriers (Correct answer)
Providing identical services to all patients regardless of need
Distributing medications equally across all demographic groups

Correct answer: Achieving the highest level of health for all people by addressing systemic barriers

Health equity means removing systemic, social, and environmental barriers so everyone can attain their highest possible level of health.

Question 60: An African American patient with hypertension has a BP of 148/92 mmHg. Which initial therapy is preferred based on clinical trial data and guidelines?

ACE inhibitor monotherapy
ARB monotherapy
Thiazide diuretic or calcium channel blocker (Correct answer)
Beta-blocker monotherapy

Correct answer: Thiazide diuretic or calcium channel blocker

Clinical trials (ALLHAT) show thiazide diuretics and calcium channel blockers are more effective antihypertensives in African American patients compared to ACE inhibitors or ARBs as monotherapy.

Question 61: A patient with type 2 diabetes has an eGFR of 38 mL/min/1.73 m² and a urine albumin-to-creatinine ratio (UACR) of 350 mg/g. Which pharmacological intervention has demonstrated slowing of CKD progression specifically in patients with diabetic kidney disease at this stage?

Starting high-dose loop diuretic therapy to reduce proteinuria
Discontinuing all antihypertensive medications to avoid renal hypoperfusion
Adding a calcium channel blocker (amlodipine) as the primary kidney-protective agent
Initiating a SGLT-2 inhibitor (e.g., empagliflozin or dapagliflozin) in addition to RAAS blockade (Correct answer)

Correct answer: Initiating a SGLT-2 inhibitor (e.g., empagliflozin or dapagliflozin) in addition to RAAS blockade

SGLT-2 inhibitors (empagliflozin, dapagliflozin) have demonstrated robust cardiorenal protection in patients with CKD and type 2 diabetes in landmark trials (CREDENCE, DAPA-CKD, EMPA-KIDNEY). They are now recommended by KDIGO 2022 as add-on therapy to RAAS blockade (ACE inhibitor or ARB) in patients with eGFR ≥20 and UACR ≥200 mg/g to slow CKD progression. CCBs do not slow CKD progression independently. Loop diuretics reduce volume but not proteinuria as a primary mechanism.

Question 62: A patient on atorvastatin 40 mg has LDL of 85 mg/dL but is very high-risk ASCVD. After maximizing statin dose, which add-on therapy should be considered first per ACC/AHA guidelines?

Fenofibrate
Niacin
Colesevelam
Ezetimibe (Correct answer)

Correct answer: Ezetimibe

ACC/AHA guidelines recommend adding ezetimibe as the first non-statin therapy in very high-risk patients whose LDL remains above goal on maximally tolerated statin therapy.

Question 63: A pregnant patient in her second trimester requires anticoagulation for a DVT. Which anticoagulant is safest?

Dabigatran
Rivaroxaban
Low molecular weight heparin (Correct answer)
Warfarin

Correct answer: Low molecular weight heparin

LMWH does not cross the placenta and is the recommended anticoagulant throughout pregnancy for VTE treatment.

Question 64: Which of the following correctly describes CKD Stage G3b A3 according to the KDIGO 2012 classification?

eGFR 15–29 mL/min/1.73 m² with urine albumin-to-creatinine ratio 30–300 mg/g (moderately increased albuminuria)
eGFR < 15 mL/min/1.73 m² with any level of albuminuria
eGFR 45–59 mL/min/1.73 m² with urine albumin-to-creatinine ratio < 30 mg/g (normal albuminuria)
eGFR 30–44 mL/min/1.73 m² with urine albumin-to-creatinine ratio ≥ 300 mg/g (severely increased albuminuria) (Correct answer)

Correct answer: eGFR 30–44 mL/min/1.73 m² with urine albumin-to-creatinine ratio ≥ 300 mg/g (severely increased albuminuria)

KDIGO classifies CKD using GFR categories (G1–G5) and albuminuria categories (A1: <30 mg/g, A2: 30–300 mg/g, A3: >300 mg/g). G3b = eGFR 30–44 mL/min/1.73 m², and A3 = urine ACR ≥300 mg/g (severely increased or nephrotic-range proteinuria). This combination places the patient at high-to-very-high risk for CKD progression and cardiovascular events, warranting aggressive risk factor management.

Question 65: A patient with T2DM is taking saxagliptin and develops lower extremity edema and shortness of breath. Which adverse effect of saxagliptin is most likely responsible?

Nephrotoxicity from saxagliptin
Increased risk of heart failure hospitalization (Correct answer)
Drug-induced lupus
Peripheral neuropathy exacerbation

Correct answer: Increased risk of heart failure hospitalization

The SAVOR-TIMI trial showed saxagliptin was associated with a significantly increased risk of heart failure hospitalization, an FDA-labeled warning.

Question 66: A pharmacist in a primary care clinic spends 25 minutes during a calendar month providing non-face-to-face care coordination for a Medicare patient with type 2 diabetes and heart failure. This includes telephone calls and medication reconciliation. Which CPT® code is the most appropriate to bill for these services?

99211 (Level 1 E/M Office Visit)
99605 (MTM Service, Initial)
99490 (Chronic Care Management, First 20 min) (Correct answer)
99491 (CCM, 30 min by Physician/QHP)

Correct answer: 99490 (Chronic Care Management, First 20 min)

CPT® code 99490 is designated for at least 20 minutes of clinical staff time per calendar month for non-face-to-face Chronic Care Management (CCM) services for patients with two or more chronic conditions. Since the pharmacist spent 25 minutes, this code is appropriate. 99211 is for a face-to-face visit. 99605 is for an initial MTM encounter. 99491 is for at least 30 minutes of time spent personally by a physician or other qualified healthcare professional, not clinical staff.

Question 67: A patient newly diagnosed with hypertension has a blood pressure of 158/96 mmHg and no compelling indications. According to ACC/AHA guidelines, what is the preferred initial therapy?

Alpha-blocker monotherapy
A beta-blocker as first-line monotherapy
An ARB plus a thiazide diuretic combination
A thiazide diuretic, ACE inhibitor/ARB, or calcium channel blocker (Correct answer)

Correct answer: A thiazide diuretic, ACE inhibitor/ARB, or calcium channel blocker

ACC/AHA guidelines recommend thiazide diuretics, ACE inhibitors/ARBs, or long-acting calcium channel blockers as first-line options for hypertension without compelling indications.

Question 68: A patient declines a recommended pneumococcal vaccine due to a prior unpleasant injection experience. The pharmacist's BEST approach is to:

Schedule the vaccine without further discussion
Tell the patient they are putting themselves at serious risk
Acknowledge the prior experience, offer strategies to minimize discomfort, and re-present the benefit-risk discussion (Correct answer)
Document refusal and drop the subject

Correct answer: Acknowledge the prior experience, offer strategies to minimize discomfort, and re-present the benefit-risk discussion

Acknowledging the negative experience, validating the concern, and offering comfort measures maintains trust while preserving the opportunity for informed vaccination.

Question 69: A patient with heparin-induced thrombocytopenia (HIT) requires anticoagulation. Which agent is most appropriate?

Low molecular weight heparin
Fondaparinux
Warfarin alone
Argatroban (Correct answer)

Correct answer: Argatroban

Argatroban, a direct thrombin inhibitor, is a first-line option for HIT as it does not cross-react with heparin antibodies.

Question 70: A 50-year-old woman with obesity, hypertension, and osteoarthritis seeks advice on lifestyle changes for managing her hypertension. What is the MOST effective intervention for lowering blood pressure?

Increase caffeine intake for energy
DASH diet (Correct answer)
Weight loss of 5-10% body weight (Correct answer)
Limit sodium intake to <2400 mg/day (Correct answer)
Start resistance exercise 5 days/week

Correct answer: DASH diet

The DASH (Dietary Approaches to Stop Hypertension) diet is widely recognized as the most effective dietary intervention for lowering blood pressure. It is a comprehensive eating plan rich in fruits, vegetables, whole grains, and low-fat dairy, while being low in saturated and total fats, cholesterol, and sodium. Adhering to the DASH diet can significantly reduce blood pressure and improve overall cardiovascular health.

Question 71: In a patient-centered medical home (PCMH), how is the pharmacist's role best characterized?

Sole prescriber of chronic disease medications
Independent contractor without care team communication
Integrated care team member contributing to coordinated patient care (Correct answer)
Limited to dispensing and drug distribution only

Correct answer: Integrated care team member contributing to coordinated patient care

In a PCMH, pharmacists are integrated care team members who collaborate with physicians and other providers to optimize medication use and chronic disease management.

Question 72: What is the clinical significance of the 'black box warning' on antidepressants for young adults under 25?

Increased risk of suicidal thoughts and behavior in patients under 25 (Correct answer)
Increased risk of cardiac arrhythmias
Risk of Stevens-Johnson syndrome
Risk of serotonin syndrome with all antidepressants

Correct answer: Increased risk of suicidal thoughts and behavior in patients under 25

The FDA black box warning on antidepressants states an increased risk of suicidal ideation and behavior in children, adolescents, and young adults under age 25.

Question 73: A patient refuses to take a medication because 'my neighbor took it and had terrible side effects.' Which communication strategy should the pharmacist use?

Tell the patient their neighbor's experience is irrelevant
Dismiss the concern and emphasize the physician's recommendation
Immediately change the medication to avoid resistance
Acknowledge the concern, provide individualized risk-benefit information, and explore the patient's specific worries (Correct answer)

Correct answer: Acknowledge the concern, provide individualized risk-benefit information, and explore the patient's specific worries

Acknowledging patient concerns, validating their perspective, and offering personalized risk-benefit counseling builds trust and promotes informed shared decision-making.

Question 74: A patient with limited English proficiency needs counseling about a new insulin regimen. What is the most appropriate action?

Provide written instructions in English only
Postpone counseling until the patient learns English
Ask the patient's adult child to interpret
Use a professional medical interpreter (Correct answer)

Correct answer: Use a professional medical interpreter

Professional medical interpreters ensure accurate communication and protect patient confidentiality, unlike family members who may filter or mistranslate information.

Question 75: Which opioid use disorder (OUD) medication is the ONLY one approved by the FDA that can be prescribed in an office-based setting without a special waiver historically required under the DATA 2000 Act?

Buprenorphine/naloxone
Extended-release naltrexone (Vivitrol) (Correct answer)
Tramadol
Methadone (for OUD)

Correct answer: Extended-release naltrexone (Vivitrol)

Extended-release naltrexone (injectable) has no special prescribing restrictions and can be prescribed by any licensed provider, unlike methadone for OUD (OTP only) or buprenorphine (which historically required a waiver).

Question 76: What is the purpose of providing Tdap (rather than Td) to adults who have not previously received it?

To replace annual flu vaccination
To provide additional tetanus coverage
To protect against pertussis (whooping cough) in addition to tetanus and diphtheria (Correct answer)
To prevent hepatitis A

Correct answer: To protect against pertussis (whooping cough) in addition to tetanus and diphtheria

Tdap includes the pertussis component, which is important for reducing community transmission and protecting vulnerable contacts such as infants.

Question 77: Which fluoroquinolone interaction most significantly prolongs the QT interval and requires monitoring?

Ciprofloxacin with metformin
Levofloxacin with warfarin
Ciprofloxacin with antacids
Moxifloxacin with amiodarone (Correct answer)

Correct answer: Moxifloxacin with amiodarone

Moxifloxacin combined with amiodarone poses a serious additive QT prolongation risk that can lead to torsades de pointes.

Question 78: In a clinical study, researchers conclude that a new therapy is superior to placebo (p=0.04). In reality, however, no true difference exists between the therapy and placebo. What type of error has occurred?

Selection bias
Type II error
Confounding bias
Type I error (Correct answer)

Correct answer: Type I error

A Type I error occurs when the null hypothesis (which states there is no difference) is incorrectly rejected. In this case, the researchers concluded there was a difference (rejected the null hypothesis) when one did not actually exist. This is also known as a 'false positive.' The probability of making a Type I error is represented by alpha (α), which is the p-value threshold for statistical significance (commonly set at 0.05).

Question 79: Which of the following statements correctly describes the timing of initiating hormone therapy (HT) for menopausal symptom management according to current evidence and guidelines?

HT should be avoided in all women over age 50 due to cardiovascular risk
HT is most beneficial and carries the lowest risk when initiated within 10 years of menopause onset or before age 60 (Correct answer)
HT should only be initiated when a woman is over 65 and symptoms are severe
HT efficacy is equivalent regardless of when it is initiated after menopause

Correct answer: HT is most beneficial and carries the lowest risk when initiated within 10 years of menopause onset or before age 60

The 'timing hypothesis' (or 'window of opportunity') is a key concept in menopausal hormone therapy. Evidence from the Women's Health Initiative and subsequent analyses shows that HT started within 10 years of menopause onset or before age 60 is associated with cardiovascular benefit and lower risk, whereas initiation after age 60 or more than 10 years post-menopause is associated with increased cardiovascular and stroke risk. HT is not universally contraindicated in women over 50.

Question 80: A patient taking diltiazem for rate control in atrial fibrillation is started on simvastatin 40 mg. What is the most significant drug interaction concern?

Diltiazem displaces simvastatin from plasma proteins
Diltiazem induces CYP3A4, reducing simvastatin efficacy
No clinically significant interaction exists
Diltiazem inhibits CYP3A4, increasing simvastatin exposure and risk of myopathy/rhabdomyolysis (Correct answer)

Correct answer: Diltiazem inhibits CYP3A4, increasing simvastatin exposure and risk of myopathy/rhabdomyolysis

Diltiazem is a moderate CYP3A4 inhibitor that increases simvastatin plasma concentrations significantly, raising the risk of myopathy and rhabdomyolysis; dose should be capped or a non-CYP3A4-metabolized statin used.

Question 81: Health literacy is BEST defined as:

The capacity to obtain, process, and understand health information needed to make decisions (Correct answer)
The level of formal education a patient has completed
A patient's agreement with provider recommendations
A patient's ability to read medical textbooks

Correct answer: The capacity to obtain, process, and understand health information needed to make decisions

Health literacy encompasses not only reading ability but also the cognitive and social skills needed to access and apply health information.

Question 82: Dabigatran is contraindicated for stroke prevention in atrial fibrillation when the patient's CrCl falls below which threshold?

30 mL/min (Correct answer)
40 mL/min
50 mL/min
15 mL/min

Correct answer: 30 mL/min

Dabigatran is contraindicated in nonvalvular AF when CrCl is below 30 mL/min because its approximately 80% renal elimination creates high risk of drug accumulation and serious bleeding.

Question 83: A patient on clozapine develops an ANC of 1,200 cells/mm³. According to REMS monitoring requirements, what is the correct action?

Reduce the clozapine dose by 50%
Continue clozapine with weekly ANC monitoring
Permanently discontinue clozapine
Interrupt clozapine and resume only when ANC ≥ 1,500 (Correct answer)

Correct answer: Interrupt clozapine and resume only when ANC ≥ 1,500

An ANC of 1,000–1,499 (moderate neutropenia) requires interruption of clozapine; therapy may resume when ANC returns to ≥ 1,500 cells/mm³ with more frequent monitoring.

Question 84: A patient is starting on a basal-bolus insulin regimen. What is the appropriate starting total daily dose (TDD) for an insulin-naive patient using weight-based dosing?

1.0-1.2 units/kg/day
0.2-0.3 units/kg/day
0.5-0.6 units/kg/day (Correct answer)
0.1 units/kg/day

Correct answer: 0.5-0.6 units/kg/day

A common starting TDD for basal-bolus insulin in insulin-naive patients is 0.4-0.6 units/kg/day, with half given as basal and half divided as bolus doses.

Question 85: A patient with type 2 diabetes and established CVD should preferentially receive which GLP-1 receptor agonist with proven CV mortality reduction?

Exenatide
Albiglutide
Dulaglutide
Liraglutide (Correct answer)

Correct answer: Liraglutide

Liraglutide demonstrated significant reduction in CV death, nonfatal MI, and nonfatal stroke in the LEADER trial for T2D patients with CVD.

Question 86: A 72-year-old patient with heart failure and reduced ejection fraction (HFrEF) is taking: Metoprolol succinate 25 mg daily Furosemide 40 mg daily Lisinopril 10 mg daily His symptoms are well-controlled, but his potassium is 5.4 mEq/L (normal 3.5-5.0). What is the MOST appropriate intervention?

Hold Lisinopril temporarily (Correct answer)
Start Spironolactone 25 mg daily
Increase Lisinopril to 20 mg daily
Switch Lisinopril to Sacubitril/Valsartan

Correct answer: Hold Lisinopril temporarily

The patient has hyperkalemia (potassium 5.4 mEq/L), which is a known side effect of ACE inhibitors like Lisinopril, especially in patients with heart failure or renal impairment. Since Lisinopril contributes to potassium retention, temporarily holding the medication is the most appropriate immediate intervention to allow potassium levels to normalize and prevent further elevation. Once potassium is controlled, the need for an ACE inhibitor can be re-evaluated.

Question 87: A woman of childbearing age is starting valproic acid for epilepsy. Which intervention is MOST important for a pharmacist to address during preconception counseling?

Recommend switching to carbamazepine, which is safer in pregnancy
No additional counseling is needed as all antiepileptic drugs carry equal risk
Recommend discontinuing all antiepileptic drugs before attempting pregnancy
Advise high-dose folic acid supplementation (4 mg/day) and discuss teratogenic risk (Correct answer)

Correct answer: Advise high-dose folic acid supplementation (4 mg/day) and discuss teratogenic risk

Valproic acid is a major teratogen (associated with neural tube defects, facial anomalies, and cognitive impairment — fetal valproate syndrome). High-dose folic acid (4–5 mg/day) is recommended preconceptionally to reduce neural tube defect risk. Women should be counseled on these risks and, if possible, switched to a safer alternative by their neurologist. However, the pharmacist's role is to ensure folic acid is prescribed and risks discussed — not to unilaterally discontinue therapy. Carbamazepine also carries teratogenic risk and is not necessarily safer.

Question 88: Which key counseling point should a pharmacist provide when dispensing oseltamivir (Tamiflu) for influenza?

It should be taken on an empty stomach only
It can be taken once weekly for prophylaxis only
It cures influenza and prevents future infections
It must be started within 48 hours of symptom onset to be effective (Correct answer)

Correct answer: It must be started within 48 hours of symptom onset to be effective

Oseltamivir reduces illness duration but must be initiated within 48 hours of symptom onset for optimal benefit.

Question 89: A patient is prescribed sacubitril/valsartan for HFrEF. What is the required washout period before starting this drug if the patient was previously taking an ACE inhibitor?

36 hours (Correct answer)
12 hours
24 hours
48 hours

Correct answer: 36 hours

A 36-hour washout period is required after stopping an ACE inhibitor before starting sacubitril/valsartan to prevent life-threatening angioedema.

Question 90: What is the mechanism by which PCSK9 inhibitors reduce LDL-C levels?

Block HMG-CoA reductase enzyme
Activate LPL to clear VLDL particles
Prevent PCSK9 from degrading LDL receptors (Correct answer)
Inhibit cholesterol absorption in the gut

Correct answer: Prevent PCSK9 from degrading LDL receptors

PCSK9 inhibitors prevent PCSK9 from binding to and degrading LDL receptors, allowing more receptors to remain on hepatocytes to clear LDL-C.

Question 91: Motivational interviewing (MI) is an evidence-based counseling technique. Which of the following BEST describes MI?

Directing patients on exactly what they should do to improve health
Using fear-based messaging to emphasize consequences of non-adherence
Educating patients about disease pathophysiology to increase awareness
A collaborative, goal-oriented communication style that elicits patient motivation for change (Correct answer)

Correct answer: A collaborative, goal-oriented communication style that elicits patient motivation for change

Motivational interviewing is a patient-centered counseling approach that helps patients explore and resolve ambivalence to promote behavior change.

Question 92: A patient taking phenelzine (an MAOI) for treatment-resistant depression requests tramadol for pain. What is the MOST serious risk of this combination?

Serotonin syndrome (Correct answer)
Excessive sedation only
Prolonged QTc interval
Hypertensive crisis

Correct answer: Serotonin syndrome

Tramadol inhibits serotonin reuptake and combined with an MAOI creates a potentially life-threatening serotonin syndrome.

Question 93: A 38-year-old woman with polycystic ovary syndrome (PCOS) presents with irregular menses and difficulty conceiving. She has no diabetes but has insulin resistance. Which pharmacological agent is most commonly used off-label to improve menstrual regularity and insulin sensitivity in PCOS?

Spironolactone
Letrozole
Metformin (Correct answer)
Clomiphene citrate

Correct answer: Metformin

Metformin is used off-label in PCOS to improve insulin sensitivity, reduce androgen levels, and restore menstrual regularity. It is especially beneficial in women with insulin resistance or impaired glucose tolerance. Clomiphene and letrozole are ovulation inducers used for fertility but do not address underlying insulin resistance. Spironolactone is used for hyperandrogenism symptoms (hirsutism, acne) but does not primarily restore cycles or improve insulin sensitivity.

Question 94: A patient with COPD was just discharged from the hospital and is prescribed a new inhaled long-acting bronchodilator. Which pharmacist intervention is MOST critical within 48–72 hours post-discharge?

Confirm the patient has the inhaler, understands the correct technique, and knows when to call if symptoms worsen (Correct answer)
Verify the insurance prior authorization has been submitted
Check if the patient has a new pharmacy benefit card
Wait for the next scheduled office visit to address medication counseling

Correct answer: Confirm the patient has the inhaler, understands the correct technique, and knows when to call if symptoms worsen

Transitional care pharmacist outreach within 72 hours of discharge addresses medication access, proper technique, and red flag education to prevent readmission.

Question 95: What distinguishes BPS specialty certification from membership in a professional pharmacy organization such as APhA?

BPS certification is free; APhA membership requires annual dues
APhA membership requires passing a clinical exam; BPS does not
Both require the same examination and continuing education standards
BPS certification is competency-based with examination requirements; APhA membership is based on dues payment and interest (Correct answer)

Correct answer: BPS certification is competency-based with examination requirements; APhA membership is based on dues payment and interest

BPS certification requires passing a standardized exam and meeting practice eligibility, unlike organizational membership which requires dues only.

Question 96: Which of the following BEST describes the pharmacist's role in collaborative practice agreements (CPAs) related to patient adherence?

CPAs are only applicable in inpatient hospital settings
CPAs require pharmacists to obtain a physician co-signature for every patient interaction
CPAs authorize pharmacists to initiate, adjust, or discontinue therapies under physician oversight, allowing direct adherence-related interventions (Correct answer)
CPAs limit pharmacists to dispensing functions only

Correct answer: CPAs authorize pharmacists to initiate, adjust, or discontinue therapies under physician oversight, allowing direct adherence-related interventions

CPAs expand pharmacist authority to make protocol-driven medication management decisions, enabling timely interventions that directly support adherence and therapeutic optimization.

Question 97: A pharmacist is reviewing the medication list of a patient with CKD Stage 3b (eGFR 35 mL/min/1.73 m²). The patient is taking metformin 1000 mg twice daily for type 2 diabetes. What action should the pharmacist recommend?

Reduce metformin dose and continue with more frequent monitoring of renal function (Correct answer)
Switch to a sulfonylurea such as glibenclamide (glyburide) as the safer alternative
Discontinue metformin immediately as it is absolutely contraindicated below eGFR 60
Continue metformin at the current dose without any modifications

Correct answer: Reduce metformin dose and continue with more frequent monitoring of renal function

Per FDA labeling updated in 2016 and KDIGO/ADA guidelines, metformin can be continued with dose reduction and increased monitoring when eGFR is 30–45 mL/min/1.73 m² (CKD Stage 3b). At eGFR 35, continuing at a reduced dose with close renal monitoring is appropriate. Metformin is contraindicated below eGFR 30 due to lactic acidosis risk. Glyburide is actually more dangerous in CKD due to active metabolite accumulation causing hypoglycemia.

Question 98: A 72-year-old woman with hypertension, osteoporosis, and no prior CV events has a 10-year ASCVD risk of 9%. The clinician and patient are uncertain about statin therapy. What is the most appropriate next step?

Use risk-enhancing factors to guide the statin discussion (Correct answer)
Defer all treatment for 2 years
Start high-intensity statin immediately
Start aspirin therapy instead of statin

Correct answer: Use risk-enhancing factors to guide the statin discussion

For borderline-risk patients (7.5–20%), ACC/AHA guidelines recommend using risk-enhancing factors to refine the statin initiation decision.

Question 99: A patient with resistant hypertension (BP 158/96 mmHg on maximally tolerated doses of ACE inhibitor, calcium channel blocker, and thiazide diuretic) is being evaluated. What is the most appropriate add-on agent?

Amlodipine (already on CCB, would add another of same class)
Spironolactone (Correct answer)
Doxazosin
Clonidine

Correct answer: Spironolactone

Spironolactone is the preferred 4th-line agent for resistant hypertension, as mineralocorticoid excess is common in this population and spironolactone has demonstrated superior BP reduction over other add-on agents in trials like PATHWAY-2.

Question 100: A patient newly diagnosed with osteoporosis has a T-score of -3.1 at the hip. They are intolerant of oral bisphosphonates. Which therapy is most appropriate?

Calcitonin nasal spray
Calcium and vitamin D supplementation only
Zoledronic acid 5 mg IV annually (Correct answer)
Raloxifene 60 mg orally daily

Correct answer: Zoledronic acid 5 mg IV annually

Zoledronic acid is a first-line IV bisphosphonate option that offers annual dosing with proven fracture reduction benefit, appropriate for patients intolerant of oral formulations.

Question 101: Which insulin type has the longest duration of action and is typically dosed once or twice daily as basal insulin?

Insulin degludec (Correct answer)
Regular insulin
Insulin NPH
Insulin lispro

Correct answer: Insulin degludec

Insulin degludec (Tresiba) has an ultra-long duration of action (>42 hours), making it suitable for once-daily basal dosing with a flat peakless profile.

Question 102: Which antimicrobial is first-line for treatment of Clostridioides difficile (C. diff) infection of non-severe initial episodes per IDSA/SHEA guidelines?

Clindamycin
Metronidazole (IV)
Oral vancomycin or fidaxomicin (Correct answer)
Ciprofloxacin

Correct answer: Oral vancomycin or fidaxomicin

IDSA/SHEA guidelines recommend oral vancomycin or fidaxomicin over metronidazole for initial non-severe C. difficile infection due to superior cure rates.

Question 103: In a survival analysis, which graphical method is used to display time-to-event data comparing two treatment groups?

Forest plot
Kaplan-Meier curve (Correct answer)
Funnel plot
Box-and-whisker plot

Correct answer: Kaplan-Meier curve

Kaplan-Meier curves display the probability of survival over time and allow visual comparison between groups.

Question 104: A meta-analysis reports an I² statistic of 75%. How should this be interpreted?

75% of studies show statistical significance
High heterogeneity exists among the included studies (Correct answer)
The pooled effect is highly precise
Low heterogeneity exists among the included studies

Correct answer: High heterogeneity exists among the included studies

An I² of ≥75% indicates substantial heterogeneity, questioning the validity of pooling results.

Question 105: A patient with ASCVD on maximum-tolerated statin therapy has LDL-C of 95 mg/dL. Which add-on therapy has outcomes data showing reduced CV events?

Fibrates
Niacin
Omega-3 fatty acids
Ezetimibe (Correct answer)

Correct answer: Ezetimibe

The IMPROVE-IT trial demonstrated that adding ezetimibe to statin therapy reduced major cardiovascular events in high-risk patients.

Question 106: A patient starting warfarin therapy has a CYP2C9 2/3 genotype. What clinical implication does this have?

Patient will require higher than average warfarin doses
No dose adjustment needed as genotype doesn't affect warfarin
Patient should receive a DOAC instead
Patient will require lower than average warfarin doses due to reduced enzyme activity (Correct answer)

Correct answer: Patient will require lower than average warfarin doses due to reduced enzyme activity

CYP2C9 *2 and *3 alleles encode enzymes with reduced activity, leading to decreased warfarin metabolism and lower dose requirements.

Question 107: The FOURIER trial demonstrated cardiovascular benefit for which medication class in patients with established ASCVD on statin therapy?

Fibrates
SGLT2 inhibitors
Omega-3 fatty acids
PCSK9 inhibitors (Correct answer)

Correct answer: PCSK9 inhibitors

FOURIER showed that evolocumab (a PCSK9 inhibitor) significantly reduced major CV events in patients with ASCVD already on statin therapy.

Question 108: Which laboratory finding would be an absolute contraindication to initiating an aldosterone antagonist in a patient with HFrEF?

Hemoglobin <10 g/dL
Serum potassium ≥5.0 mEq/L or eGFR <30 mL/min (Correct answer)
Total bilirubin >2 mg/dL
Serum sodium <135 mEq/L

Correct answer: Serum potassium ≥5.0 mEq/L or eGFR <30 mL/min

Aldosterone antagonists are contraindicated when serum potassium is ≥5.0 mEq/L due to severe hyperkalemia risk, or when eGFR is <30 mL/min due to impaired potassium excretion.

Question 109: Pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine (Truvada) is indicated for which patient population?

All sexually active adults regardless of risk
Patients with chronic hepatitis C
HIV-negative individuals at high risk for HIV acquisition (Correct answer)
HIV-positive individuals on ART

Correct answer: HIV-negative individuals at high risk for HIV acquisition

PrEP is indicated for HIV-negative adults at substantial ongoing risk of HIV, such as those with high-risk sexual behavior or injection drug use.

Question 110: Which study design provides the highest level of evidence for evaluating therapeutic interventions?

Case-control study
Well-designed cohort study
Systematic review with meta-analysis of randomized controlled trials (Correct answer)
Expert opinion

Correct answer: Systematic review with meta-analysis of randomized controlled trials

Systematic reviews with meta-analyses of RCTs sit at the top of the evidence hierarchy for therapeutic questions.

Question 111: Which lipid-lowering drug is most associated with flushing as a side effect and requires premedication with aspirin?

Niacin (nicotinic acid) (Correct answer)
Fenofibrate
Ezetimibe
Colesevelam

Correct answer: Niacin (nicotinic acid)

Niacin causes prostaglandin-mediated cutaneous flushing; taking 325 mg aspirin 30 minutes before the dose significantly reduces this effect.

Question 112: A 45-year-old patient who smokes one pack per day expresses a desire to quit. His medical history is significant for a well-controlled seizure disorder. Which of the following is the most appropriate first-line pharmacotherapy recommendation?

Nortriptyline
Varenicline
Bupropion SR
Nicotine patch + nicotine lozenge (Correct answer)

Correct answer: Nicotine patch + nicotine lozenge

Bupropion is contraindicated in patients with a history of a seizure disorder as it can lower the seizure threshold. Varenicline is a first-line option, but combination nicotine replacement therapy (NRT)—such as a nicotine patch for long-acting control plus a lozenge for short-acting craving relief—is a highly effective and safe first-line option that completely avoids the contraindication associated with bupropion. Nortriptyline is considered a second-line agent for smoking cessation.

Question 113: A pharmacist reviews a patient's chart and notes the patient has not received a Td booster in 12 years. What is the appropriate action?

Administer Td booster now if no previous Tdap history, otherwise Tdap (Correct answer)
No action needed; tetanus boosters are only required after injuries
Administer Tdap regardless of prior Tdap history
Refer to infectious disease before any booster

Correct answer: Administer Td booster now if no previous Tdap history, otherwise Tdap

Td/Tdap is recommended every 10 years; if the patient has never received Tdap, it should be given as the booster to confer pertussis protection.

Question 114: A population health dashboard shows that 68% of patients with atrial fibrillation are on anticoagulation therapy. The most appropriate benchmark to compare this rate against is:

Evidence-based guideline recommendations and peer health system comparators (Correct answer)
The pharmacy's historical dispensing volume for anticoagulants
National average statin use in heart failure patients
Individual patient satisfaction scores with anticoagulation counseling

Correct answer: Evidence-based guideline recommendations and peer health system comparators

Benchmarking against clinical guidelines and peer health systems provides meaningful context for evaluating and improving population-level performance.

Question 115: In a crossover trial, which design feature helps control for carryover effects?

Use of placebo in the control arm
Randomization of treatment sequence
Blinding of participants
Washout period between treatment phases (Correct answer)

Correct answer: Washout period between treatment phases

A washout period allows prior treatment effects to dissipate before the next phase begins, controlling for carryover.

Question 116: Which measurement framework, commonly used in ambulatory care pharmacy, assesses quality across Structure, Process, and Outcome domains?

Six Sigma DMAIC
Triple Aim Framework
Balanced Scorecard
Donabedian Model (Correct answer)

Correct answer: Donabedian Model

The Donabedian Model evaluates healthcare quality through three domains: Structure (resources/settings), Process (care delivery activities), and Outcomes (patient results).

Question 117: A pharmacist reviews a patient's chart and notes MRSA bacteremia. Which antibiotic is the drug of choice?

Clindamycin
Ceftriaxone
Linezolid
Vancomycin (Correct answer)

Correct answer: Vancomycin

Vancomycin remains the standard of care for MRSA bacteremia in ambulatory and inpatient settings.

Question 118: A patient with bipolar I disorder is stable on lithium but becomes pregnant. What is the primary concern with continuing lithium?

Risk of premature birth
Risk of Ebstein's anomaly (cardiac defect) in the fetus (Correct answer)
Risk of neonatal seizures
Risk of neonatal hypoglycemia

Correct answer: Risk of Ebstein's anomaly (cardiac defect) in the fetus

Lithium use in the first trimester is associated with Ebstein's anomaly, a rare but serious cardiac malformation.

Question 119: A patient reports taking St. John's Wort daily. Which prescribed medication is most at risk for therapeutic failure due to this interaction?

Cyclosporine (Correct answer)
Lisinopril
Atorvastatin
Ibuprofen

Correct answer: Cyclosporine

St. John's Wort is a potent inducer of CYP3A4 and P-glycoprotein, dramatically reducing cyclosporine levels and risking acute organ rejection in transplant patients.

Question 120: A pharmacist reviews claims data and finds that 40% of patients with heart failure have not filled their ACE inhibitor prescription in the past 90 days. The BEST next action to address this at the population level is to:

Wait for patients to report symptoms before intervening
Send a letter to all prescribers requesting they re-prescribe ACE inhibitors
Remove ACE inhibitors from the formulary and substitute ARBs
Stratify patients by non-adherence severity and prioritize outreach to highest-risk patients (Correct answer)

Correct answer: Stratify patients by non-adherence severity and prioritize outreach to highest-risk patients

Risk stratification allows targeted outreach to those most likely to experience harm from non-adherence, maximizing the impact of limited resources.

Question 121: A 48-year-old male with no history of ASCVD has a 10-year ASCVD risk of 15% calculated using the PREVENT equations. His LDL-C is 145 mg/dL despite lifestyle modifications. According to the 2026 ACC/AHA Dyslipidemia Guideline, which of the following is the most appropriate initial therapy?

Atorvastatin 40 mg daily (Correct answer)
Ezetimibe 10 mg daily
Pravastatin 20 mg daily
Lovastatin 10 mg daily

Correct answer: Atorvastatin 40 mg daily

For primary prevention in a patient with an intermediate to high 10-year ASCVD risk (≥7.5% to <20%), guidelines recommend initiating a moderate-intensity statin. However, given the risk of 15% and an LDL-C well above the goal of <100 mg/dL, initiating a high-intensity statin like atorvastatin 40 mg to achieve at least a 50% reduction in LDL-C is a reasonable and often preferred approach. Atorvastatin 40 mg is a high-intensity statin, while pravastatin 20 mg and lovastatin 10 mg are low-intensity. Ezetimibe is not a first-line agent for primary prevention.

Question 122: A 68-year-old male diagnosed with symptomatic peripheral artery disease (PAD), confirmed by an ankle-brachial index of 0.75, is not currently on any antiplatelet or anticoagulant therapy. Which of the following is the most appropriate initial agent to reduce his risk of major adverse cardiovascular events?

Aspirin 81 mg plus ticagrelor 90 mg twice daily
Clopidogrel 75 mg daily (Correct answer)
Apixaban
Warfarin

Correct answer: Clopidogrel 75 mg daily

The 2016 AHA/ACC guidelines recommend antiplatelet therapy for symptomatic PAD to reduce the risk of myocardial infarction, stroke, and vascular death. Aspirin (75-325 mg daily) or clopidogrel (75 mg daily) are both appropriate first-line choices (Class I recommendation). Anticoagulants like warfarin or apixaban are not indicated for PAD risk reduction alone. Dual antiplatelet therapy is not routinely recommended for chronic PAD management without a compelling concurrent indication like a recent coronary stent.

Question 123: Which federal program requires that pharmacists providing MTM services complete a comprehensive medication review (CMR) at least annually for eligible enrollees?

Veterans Choice Program
CHIP Managed Care Program
Medicaid EPSDT Program
Medicare Part D MTM Program (Correct answer)

Correct answer: Medicare Part D MTM Program

CMS requires Medicare Part D plan sponsors to offer a CMR at least annually to all eligible MTM program enrollees, with the pharmacist documenting a written summary.

Question 124: Which stimulant medication for ADHD is classified as Schedule II and requires a new written prescription for each fill with NO refills permitted?

Viloxazine (Qelbree)
Guanfacine extended-release (Intuniv)
Atomoxetine (Strattera)
Methylphenidate (Ritalin) (Correct answer)

Correct answer: Methylphenidate (Ritalin)

Methylphenidate is a Schedule II controlled substance; federal law prohibits refills, and a new prescription is required for each 30-day supply.

Question 125: A patient with peripheral arterial disease (PAD) and hypertension asks if beta-blockers are contraindicated. What is the most accurate response?

Beta-blockers must be avoided if the ABI is below 0.9
Beta-blockers are not contraindicated in PAD and may be used when indicated for comorbidities (Correct answer)
Only non-selective beta-blockers are contraindicated in PAD
Beta-blockers are absolutely contraindicated in all PAD patients

Correct answer: Beta-blockers are not contraindicated in PAD and may be used when indicated for comorbidities

Current evidence does not support avoiding beta-blockers in PAD; they are indicated for comorbid conditions such as CAD, HF, or post-MI and do not worsen claudication significantly.

Question 126: Which direct oral anticoagulant (DOAC) requires dose adjustment based on a combination of age, weight, AND serum creatinine?

Edoxaban
Dabigatran
Rivaroxaban
Apixaban (Correct answer)

Correct answer: Apixaban

Apixaban dose reduction requires meeting at least 2 of 3 criteria: age ≥80, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL.

Question 127: A hospital system is hiring for a clinical pharmacist position in an ambulatory care clinic and lists BCACP as 'preferred.' What does this suggest about the role?

The position requires prescriptive authority
The position involves primarily dispensing, not clinical services
BCACP is legally required for outpatient pharmacy positions in that state
The employer values demonstrated specialty competence in ambulatory care practice (Correct answer)

Correct answer: The employer values demonstrated specialty competence in ambulatory care practice

Employers listing BCACP as preferred signal that they value advanced clinical expertise specific to ambulatory care.

Question 128: A 45-year-old patient with prediabetes has been advised to start a regular exercise program. During a follow-up visit, he states, "I know I need to exercise, and I've been thinking about joining a gym for the past few months, but I haven't taken any steps yet." According to the Transtheoretical Model of Change, which stage is this patient most likely in?

Precontemplation
Preparation
Action
Contemplation (Correct answer)

Correct answer: Contemplation

The patient is in the Contemplation stage. He is aware of the problem and is thinking about making a change within the next six months but has not yet made a specific commitment or plan to take action. Precontemplation would involve no intention to change, Preparation would involve making specific plans, and Action involves actively engaging in the new behavior.

Question 129: A pharmacist is evaluating a patient's medication regimen for polypharmacy. Which approach BEST reduces adherence burden while maintaining therapeutic goals?

Refer the patient to their primary care provider without further pharmacist action
Add an adherence monitoring app without changing the regimen
Conduct a comprehensive medication review to identify candidates for deprescribing, combination products, or synchronization (Correct answer)
Discontinue all medications with low evidence ratings immediately

Correct answer: Conduct a comprehensive medication review to identify candidates for deprescribing, combination products, or synchronization

Systematic medication review identifying opportunities for deprescribing, combination tablets, and refill synchronization reduces regimen complexity and improves adherence.

Question 130: A pharmacist in a Comprehensive Primary Care Plus (CPC+) practice earns a care management fee for patients with multiple chronic conditions. This fee is BEST described as:

A retrospective bonus based on quality scores only
A prospective per-member per-month payment for care coordination (Correct answer)
A shared savings payment distributed annually
A one-time payment per diagnosis

Correct answer: A prospective per-member per-month payment for care coordination

CPC+ provides prospective monthly care management fees to practices for high-need patients, supporting the cost of team-based care coordination including pharmacists.

Question 131: A pharmacist is establishing a new transitions of care service in a health system. To ensure the service is financially sustainable, a key component of the practice management plan is to identify appropriate billing mechanisms. Which of the following represents a viable billing strategy for pharmacist-led transitions of care services under Medicare?

Billing directly under the pharmacist’s provider number using MTM codes.
Using facility fees only, as no professional service codes apply.
Billing 'incident-to' a physician for services provided in the outpatient clinic post-discharge. (Correct answer)
Enrolling the pharmacy as a durable medical equipment (DME) supplier.

Correct answer: Billing 'incident-to' a physician for services provided in the outpatient clinic post-discharge.

Since pharmacists are not recognized Medicare Part B providers, they cannot bill directly for most clinical services. However, services provided in an outpatient clinic as part of post-discharge follow-up can often be billed under the 'incident-to' provision, where the service is billed under the physician's provider number as an integral part of the physician's care. MTM codes are generally not reimbursed by Medicare Part B. Facility fees may apply but do not cover the professional component of the service, and becoming a DME supplier is not relevant to billing for cognitive services.

Question 132: Which adverse effect is most commonly associated with the use of inhaled corticosteroids in ambulatory asthma patients?

Oropharyngeal candidiasis (Correct answer)
Osteoporosis
Hyperglycemia
Adrenal suppression

Correct answer: Oropharyngeal candidiasis

Oropharyngeal candidiasis is the most common local adverse effect of inhaled corticosteroids, mitigated by rinsing the mouth after each use.

Question 133: Researchers wish to determine if exposure to a certain workplace chemical is associated with the development of a rare form of cancer. They identify a group of individuals with the cancer (cases) and a similar group without the cancer (controls). They then look back in time, using work history records, to determine the rate of chemical exposure in each group. Which study design does this describe?

Randomized Controlled Trial
Prospective Cohort Study
Case-Control Study (Correct answer)
Cross-Sectional Study

Correct answer: Case-Control Study

This describes a case-control study. This design starts by identifying individuals with the outcome of interest (cases) and a comparable group without the outcome (controls). It then looks retrospectively to compare the frequency of exposure to a risk factor in both groups. A prospective cohort study would start with exposed and unexposed groups and follow them forward in time to see who develops the disease.

Question 134: Which of the following lifestyle modifications is consistently shown to have the most significant impact on lowering blood pressure?

Engaging in regular aerobic exercise
Increasing dietary potassium intake
Reducing dietary sodium intake (Correct answer)
Moderating alcohol consumption

Correct answer: Reducing dietary sodium intake

While all listed lifestyle modifications are important and recommended for managing hypertension, reducing dietary sodium intake, particularly by following the DASH diet, has been demonstrated to have the most substantial effect on lowering blood pressure, especially in salt-sensitive individuals. The effect of sodium restriction is often more pronounced than that of potassium supplementation, exercise, or alcohol moderation alone.

Question 135: An ambulatory care pharmacist wants to quickly screen a new patient for potential health literacy challenges. Which of the following is a validated, single-question screening tool for this purpose?

"How often do you have problems learning about your medical condition because of difficulty understanding written information?" (Correct answer)
"What is your highest level of education completed?"
"Can you read this prescription label and tell me how you would take the medication?"
"Do you always take your medications exactly as prescribed?"

Correct answer: "How often do you have problems learning about your medical condition because of difficulty understanding written information?"

The question, "How often do you have problems learning about your medical condition because of difficulty understanding written information?" is a version of the validated Single Item Literacy Screener (SILS). The SILS is a brief, effective tool used to quickly identify patients who may have limited health literacy and need assistance with health-related materials. Education level is a poor predictor of health literacy, and the other options are functional assessments or adherence questions, not validated literacy screening tools.

Question 136: A pharmacist with a PGY-2 ambulatory care residency but fewer than 3 years of post-residency practice asks about BCACP eligibility. Which statement is most accurate?

They must obtain BCPS certification first as a prerequisite
PGY-2 residency training is not recognized by BPS for eligibility purposes
A PGY-2 ambulatory care residency may fulfill the BPS practice eligibility pathway (Correct answer)
They are ineligible until completing 3 years of any pharmacy practice

Correct answer: A PGY-2 ambulatory care residency may fulfill the BPS practice eligibility pathway

BPS accepts completion of a PGY-2 ambulatory care residency as an alternative eligibility pathway for the BCACP exam.

Question 137: A patient with HFrEF and iron-deficiency anemia (ferritin <100 ng/mL, transferrin saturation <20%) is being optimized. Which intervention has demonstrated improved symptoms and quality of life?

Erythropoiesis-stimulating agents
Intravenous ferric carboxymaltose (Correct answer)
Blood transfusion
Oral ferrous sulfate

Correct answer: Intravenous ferric carboxymaltose

Intravenous ferric carboxymaltose has demonstrated improved exercise capacity, symptoms, and quality of life in HFrEF patients with iron deficiency, unlike oral iron which has shown limited benefit.

Question 138: Which of the following best defines a surrogate endpoint?

A biomarker used as a substitute for a clinically meaningful outcome (Correct answer)
The primary outcome measured in a trial
A secondary endpoint pre-specified in the protocol
An endpoint used only in pharmacokinetic studies

Correct answer: A biomarker used as a substitute for a clinically meaningful outcome

Surrogate endpoints are biomarkers (e.g., HbA1c, LDL-C) assumed to correlate with clinical outcomes but may not capture true patient benefit.

Question 139: According to AHA/ACC guidelines, oral anticoagulation is RECOMMENDED (not merely considered) for males with nonvalvular atrial fibrillation when their CHA2DS2-VASc score reaches:

4 or greater
3 or greater
2 or greater (Correct answer)
1 or greater

Correct answer: 2 or greater

AHA/ACC guidelines recommend oral anticoagulation for males with nonvalvular AF and CHA2DS2-VASc score of 2 or greater; a score of 1 makes anticoagulation reasonable but not definitively recommended.

Question 140: Which atypical antipsychotic requires mandatory enrollment in a REMS program due to risk of agranulocytosis?

Clozapine (Correct answer)
Aripiprazole
Quetiapine
Risperidone

Correct answer: Clozapine

Clozapine has a REMS program (CLOZAPINE REMS) requiring ANC monitoring due to its risk of life-threatening agranulocytosis.

Question 141: A 30-year-old woman presents with a second UTI in 6 months. She is otherwise healthy. Which strategy is evidence-based for recurrent UTI prevention?

Cranberry juice only
Continuous daily prophylactic antibiotics or post-coital prophylaxis (Correct answer)
Prophylactic fluconazole
Daily urinalysis monitoring

Correct answer: Continuous daily prophylactic antibiotics or post-coital prophylaxis

Continuous low-dose prophylaxis or post-coital antibiotic prophylaxis are evidence-based strategies for reducing recurrent UTI frequency in women.

Question 142: Which non-HDL cholesterol target is recommended for very high-risk cardiovascular patients per current guidelines?

<70 mg/dL
<55 mg/dL
<130 mg/dL
<100 mg/dL (Correct answer)

Correct answer: <100 mg/dL

Non-HDL-C goal for very high-risk patients is <100 mg/dL, which corresponds to an LDL-C goal of <70 mg/dL plus 30 mg/dL.

Question 143: A patient with COPD is prescribed tiotropium via HandiHaler. Which counseling point is most critical for proper use?

Inhale slowly and deeply, hold breath for 10 seconds, and do not swallow the capsule (Correct answer)
Inhale quickly and forcefully to aerosolize the medication
Use with a spacer device for optimal lung deposition
Rinse mouth after each use to prevent candidiasis

Correct answer: Inhale slowly and deeply, hold breath for 10 seconds, and do not swallow the capsule

Tiotropium HandiHaler requires slow deep inhalation to ensure dry powder deposition in the airways; capsules are perforated in the device and must never be swallowed.

Question 144: A patient with uncontrolled hypertension states, "I know I should take my blood pressure pills, but I hate the side effects and I don't feel any different when I take them." Which response from the pharmacist best demonstrates the spirit of motivational interviewing?

"Why aren't you taking them? Don't you understand how important this is?"
"If you don't take your medication, you're at a very high risk for a stroke or heart attack."
"It sounds like you're frustrated that the medications make you feel worse without any noticeable benefit." (Correct answer)
"Let's switch you to a different medication that has fewer side effects. That will solve the problem."

Correct answer: "It sounds like you're frustrated that the medications make you feel worse without any noticeable benefit."

This response uses reflective listening and expresses empathy, which are key principles of motivational interviewing. It validates the patient's feelings and opens a non-judgmental space to discuss their ambivalence, rather than using scare tactics, offering premature solutions, or asking confrontational questions.

Question 145: A pharmacist reviews a randomized controlled trial comparing a new lipid-lowering agent to placebo. The primary endpoint was major adverse cardiovascular events (MACE). The event rate in the placebo group was 12% and in the new agent group was 8%. What is the number needed to treat (NNT) to prevent one MACE?

8
4
12
25 (Correct answer)

Correct answer: 25

The Number Needed to Treat (NNT) is the reciprocal of the Absolute Risk Reduction (ARR). First, calculate the ARR: ARR = (Event Rate in Control Group) - (Event Rate in Treatment Group) = 12% - 8% = 4% or 0.04. Then, calculate the NNT: NNT = 1 / ARR = 1 / 0.04 = 25. This means 25 patients need to be treated with the new agent to prevent one additional MACE compared to placebo.

Question 146: A patient with T2DM develops recurrent genital mycotic infections after starting empagliflozin. What is the mechanism behind this adverse effect?

Increased urinary glucose promotes fungal growth (Correct answer)
Direct antifungal resistance induction
Increased urinary pH favoring Candida
Immune suppression from glucosuria

Correct answer: Increased urinary glucose promotes fungal growth

SGLT2 inhibitors increase urinary glucose excretion (glucosuria), creating an environment that promotes Candida and other fungal infections of the genitourinary tract.

Question 147: In a value-based contract, a pharmacy service is penalized if its diabetes patient population's average HbA1c remains above 9%. This is an example of:

Prospective payment system penalty
Capitated reimbursement adjustment
Pay-for-performance quality withhold (Correct answer)
Fee-for-service clawback provision

Correct answer: Pay-for-performance quality withhold

Pay-for-performance contracts include financial incentives or penalties tied to achievement of specific quality benchmarks.

Question 148: A patient reports taking their antihypertensive medication 'most of the time.' The BEST follow-up question is:

'Don't you understand how dangerous high blood pressure is?'
'Can you tell me what a typical day looks like when you do and don't take your medication?' (Correct answer)
'Should I tell your doctor you're non-compliant?'
'Why aren't you taking it every day?'

Correct answer: 'Can you tell me what a typical day looks like when you do and don't take your medication?'

Open-ended, non-judgmental questions about daily routines reveal patterns and practical barriers to adherence without creating defensiveness.

Question 149: A patient newly diagnosed with heart failure asks why they need to weigh themselves daily. What is the BEST explanation?

Daily weight helps track caloric intake for dietary counseling
Weight monitoring is only necessary when symptoms worsen
Daily weight is required to adjust statin dosing
Sudden weight gain (2-3 lbs in a day or 5 lbs in a week) indicates fluid retention and signals worsening heart failure requiring prompt attention (Correct answer)

Correct answer: Sudden weight gain (2-3 lbs in a day or 5 lbs in a week) indicates fluid retention and signals worsening heart failure requiring prompt attention

Fluid retention from worsening heart failure causes rapid weight gain, and daily monitoring allows early detection before severe decompensation occurs.

Question 150: A pharmacist practice at a retail pharmacy chain wants to offer clinical services. The PRIMARY regulatory barrier is MOST likely:

Lack of CPT codes for pharmacy services
State scope-of-practice laws limiting pharmacist prescriptive authority (Correct answer)
Absence of pharmacy benefit manager interest
Federal prohibition on pharmacy-based clinical services

Correct answer: State scope-of-practice laws limiting pharmacist prescriptive authority

State-specific scope-of-practice legislation is the primary regulatory determinant of what clinical services pharmacists may legally provide.

Board Certified Ambulatory Care Pharmacist (BCACP) Exam

The BCACP certification, administered by the Board of Pharmacy Specialties (BPS), validates a pharmacist's advanced competency in ambulatory care practice including patient-centered medication therapy management, clinical literature interpretation, and population-based care.

150

Questions

225 min

Time Limit

62%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds